BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06432036 updates: 1. completion date: 2027-06-01 → 2030-03-01 2. primary completion date: 2026-06-01 → 2029-03-24
Clinical trial NCT06432036 updates: 1. completion date: 2027-06-01 → 2030-03-01 2. primary completion date: 2026-06-01 → 2029-03-24
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical